{"url_path":"/sec/anvs/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1477845/0001104659-26-062626-index.html","accession_number":"0001104659-26-062626","cik":"0001477845","ticker":"ANVS","issuer_name":"Annovis Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1477845/0001104659-26-062626-index.html","primary_entity_key":"0001477845","primary_entity_name":"Annovis Bio, Inc."},"word_count":62,"has_tables":true,"body_markdown":"Item 5. Other Information\n\nDuring the three months ended March 31, 2026, none of our directors or \"officers,\" as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, adopted or terminated a Rule 10b5-1 trading plan or arrangement or a non-Rule 10b5-1 trading plan or arrangement, as defined in Item 408(c) of Regulation S-K.\n\n​\n\n​\n\n31\n\n[Table of Contents](#TOC)"}